Walker Robin A. 4
4 · Stoke Therapeutics, Inc. · Filed Jul 9, 2020
Insider Transaction Report
Form 4
Walker Robin A.
Chief Legal Officer
Transactions
- Sale
Common Stock
2020-07-07$22.50/sh−941$21,173→ 0 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 941 shares of Common Stock acquired under the issuer's employee stock purchase plan on June 30, 2020.